Acrodermatitis enteropathica with Pseudomonas aeruginosa sepsis.
Acrodermatitis enteropathica is characterized by eczematous and scaly plaques on the face, scalp, acral, and anogenital regions. In addition to typical lesions, unusual prominent vesiculobullous lesions are also described. We report a full-term, 9-month-old boy who has acrodermatitis enteropathica and Pseudomonas sepsis. In this patient there were clinical findings of sepsis and eczematous vesiculobullous lesions on the periorificial and acral areas. Serum zinc level was extremely low. Pseudomonas aeruginosa was identified in cultures of blood and fluid which was aspirated from the bullous lesions. After oral zinc sulfate and intravenous antibiotic treatment his condition improved within 2 weeks.
Ozkan
S
S
Department of Dermatology, Faculty of Medicine, University of Dokuz Eylül, Izmir, Turkey.
Ozkan
H
H
Fetil
E
E
Corapçioglu
F
F
Yilmaz
S
S
Ozer
E
E
D000169:Acrodermatitis / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001252:Astringents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D003677:Deficiency Diseases / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D007223:Infant; D008297:Male; D010375:Pedigree; D011552:Pseudomonas Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa; D015032:Zinc / Q000097:blood / Q000172:deficiency*; D019287:Zinc Sulfate / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001252:Astringents; D019287:Zinc Sulfate; D015032:Zinc